Voclosporin is a novel calcineurin inhibitor that functions by binding cyclophilin, consequently inhibiting calcineurin activity and preventing the transcription of many genes involved in lymphocyte proliferation and cytokine release. Voclosporin has been shown to be effective in a variety of autoimmune diseases, such as rheumatoid arthritis, psoriasis and renal transplant rejection. Noninfectious uveitis is also an immune-mediated disease which, if left untreated, can cause severe loss of vision. Presently, corticosteroids are the mainstay of therapy in noninfectious uveitis. However, there are several metabolic and ophthalmic adverse effects associated with the long-term use of corticosteroids. Voclosporin has recently been shown in the LX-211 Uveitis Multicenter Investigation of a New Approach to Treatment (LUMINATE) clinical trial program to be effective in the treatment of noninfectious uveitis. With an acceptable sideeffects profile, voclosporin is an exciting addition to the therapeutic options available in the management of noninfectious uveitis.
Keywords: blood-retinal barrier, VEGFA165b, MAPK, AKT, Endothelial blood-retinal barrier, diabetic retinopathy, image analysis, optical coherence tomography, retinal cell culture, retinal vasculature 2 ABSTRACT Purpose: Studies show that the b-isoform of Vascular Endothelial Growth Factor-A-165 (VEGFA 165 b) is predominant in normal human vitreous, switching to the a-isoform (VEGFA 165 a) in the vitreous of eyes with active diabetic retinopathy or ROP. The potential of this isoformswitching to impact the retinal vasculature is not clear, particularly in primary human retinal endothelial cells, which are important targets of VEGFA. We do not know how these two isoforms compare in their ability to activate key intracellular signalling pathways (MAPK, AKT) or alter VEGFA-target gene expression in primary human endothelial cells from the neural retina. Methods: Effects of saturating amounts of both VEGFA 165 isoforms (a/b) on the rat retinal vasculature were compared using intravitreal injection, fluorescein-angiography and Optical Coherence Tomography to monitor primary vein dilation and retinal edema. Full dose-response curves for the activation of MAPK (ERK1/2), AKT and VEGFR2 were determined using direct in-cell western assays of primary Human Retinal Microvascular Endothelial Cells (HRMECs). Differences in dose-response effects on gene expression markers related to endothelial cell / leukocyte adhesion (ICAM1, VCAM1 and SELE ) and tight-junctions (CLDN5 and OCLN ) were tested by quantitative-PCR. Results: In rats, dilation of primary retinal veins and edema could be induced within 24 hours by intravitreal injection of a saturating dose of either isoform. In HRMECs, activation dose-response analysis revealed much stronger activation of MAPK, AKT and VEGFR2 by the a-isoform at lower doses. While similar maximum activation of VEGFR2 and MAPK could be achieved by both isoforms at higher doses, maximum activation of AKT by the b-isoform was only half that observed for the a-isoform. At the level of gene expression, VEGFA 165 a was also more effective 3 at increasing expression of ICAM1, VCAM1 and SELE and decreasing expression of CLDN5 and OCLN at intermediate and high doses in primary HRMECs. Conclusions: VEGFA 165 a maximally activated MAPK and AKT in HRMECs at lower concentrations where VEGFA 165 b had little effect. The timing for maximal activation of MAPK was similar for both isoforms in HRMECs, which is different from non-retinal endothelial cells. While the dose-responses for VEGFR2 and MAPK activation had similar maximums with both isoforms, there were large differences between the isoforms in their effects on endothelial cell gene expression even at a high dose. The shifts of VEGFA 165 expression from mostly b-isoform to mostly a-isoform, as reported in some human retinal vascular diseases, could potentially impact the activation of intracellular signalling and VEGFA target gene expression in endothelial cells of the human neural retina. Receptor-2 (VEGFR2). A seminal analysis of the vitreous fluids of pati...
Background (Background, Rationale, Prior Research, and/or Theory): The ways in which food is presented can influence the amount of food selected and consumed as well as how accurately those meals are perceived and recalled. Hence, if the method of food recall is modified through the use of incrementally changing plate sizes for participants to draw their meals on, they may align their food sizes to fit the plate rather than accurately reporting portion sizes. Objective: The purpose of this study was to examine the association between plate size and meal recall through drawn food representations over a 10-week period. Study Design, Setting, Participants, Intervention: Using a longitudinal design, we had 293 undergraduate students enrolled in an introductory Nutrition lecture course draw their last night's meal for 10 weeks on either a 10.5" diameter plate, an 8.5" diameter plate, or a 10.5" diameter plate that was reduced in size by .2 inches every week. One hundred ninety-five students who completed >60% of their meal recalls, including the first and final weeks, were included for analysis. Outcome Measures and Analysis: One-way and twoway ANOVA as well as independent samples t-tests were used to compare total area, % of plate coverage, individual food group food portion size across Large, Small, and Incrementally-changing plates. Results: Participants provided with 10.5" diameter plates generally drew significantly more food on them than participants with 8.5" diameter plates (P = < .001). Participants provided with incrementally shrinking plates drew meal sizes similar to the large plates at week 1 and drew meal sizes similar to small plates by week 10. Conclusions and Implications: These findings suggest that people's conceptualization of previous meal consumption may be influenced by the size of the plate on which they draw upon, suggesting that the external environment can modify participant drawn recall of their meal sizes. Funding: None.
Case:This report describes 3 cases of Langerhans cell histiocytosis (LCH) of the cervical and thoracic spine in patients aged 4 to 10 years. Each patient had painful lytic spinal lesions with vertebral body collapse and posterior involvement suggesting instability requiring corpectomy, grafting, and fusion. All 3 patients were doing well at their most recent follow-up without pain or recurrence.Conclusion:Although LCH of the pediatric spine is usually successfully treated non-operatively, we recommend corpectomy and fusion when there is instability of the spinal column and/or severe stenosis. Posterior element involvement occurred in all 3 cases and may lead to instability.
INTRODUCTIONAnatomic body painting is described as painting the surface of the body in precise anatomically correct detail. The goal of this technique is to facilitate understanding of the spatial relations of the underlying anatomy and develop the ability to recognize clinical signs on a living subject. While the use of body painting has been explored in many international medical schools and some allied health programs in the United States, it has not been actively explored in U.S. undergraduate medical education, possibly due to the time constraints that the curriculum imposes. However, literature review shows that both students and anatomists are of the opinion that the use of anatomic body painting as an adjunct review tool facilitates active learning of the material in a more relatable and creative manner. The goal of this project is to determine whether the implementation of an anatomic body painting review session is beneficial for undergraduate medical students. Specifically, we plan to evaluate student opinions on the effectiveness and efficiency of the session in relation to other review techniques.METHODSParticipants will be invited to attend a 120‐minute anatomic body painting session developed in head and neck region with clinical correlates. Students will be divided into small groups. Each group will be provided hypo‐allergenic water‐based paint and a guide for the session that will direct them through a series of tasks that reflect the learning modalities of the head and neck. Key personnel will be present throughout the session to assist participants as needed and answer questions related to the content. Each task will involve the use of surface landmarks and palpation techniques to paint structures or regions of the head and neck while incorporating various clinical correlates for the students to discuss. A survey and assessment will be utilized at both the beginning and the end of the session to evaluate the students' confidence and understanding of the content. There will also be questions to assess their opinions about the session and its utilization in undergraduate medical curriculum.RESULTSWe anticipate that attending the anatomic body painting session will be beneficial to the students' confidence and understanding of the material and will be reflected in improved assessment scores after the session is complete. Furthermore, we expect that while participants will report spending more time reviewing the material at the session than they would have otherwise, they will find it beneficial to their overall understanding of both anatomical and clinical concepts for the head and neck.CONCLUSIONWhile anatomic body painting sessions may be more time consuming that other review modalities, it provides a unique and active learning experience for medical students that improves their overall confidence and understanding of the anatomy on a living subject. Therefore, the utilization of these sessions as an adjunct review tool in U.S. medical schools should be more closely considered.This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.